Dunmire SK, Verghese PS, Balfour HH Jr. Primary Epstein-Barr virus infection. J Clin Virol. 2018;102:84–92.

Article  PubMed  Google Scholar 

Smatti MK, Yassine HM, AbuOdeh R, AlMarawani A, Taleb S, Althani A, et al. Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar. PLoS One. 2017;12(12):e0189033.

Article  PubMed  PubMed Central  Google Scholar 

Zhang W, Chen B, Chen Y, Chamberland R, Fider-Whyte A, Craig J, et al. Epstein-Barr virus-associated acute liver failure present in a 67-year-old immunocompetent female. Gastroenterology Res. 2016;9(4–5):74–8.

Article  PubMed  PubMed Central  Google Scholar 

Teow SY, Yap HY, Peh SC. Epstein-Barr virus as a promising immunotherapeutic target for nasopharyngeal carcinoma treatment. J Pathog. 2017;2017:7349268.

PubMed  PubMed Central  Google Scholar 

Jons D, Sundström P, Andersen O. Targeting Epstein-Barr virus infection as an intervention against multiple sclerosis. Acta Neurol Scand. 2015;131(2):69–79.

Article  CAS  PubMed  Google Scholar 

Ozgurhan G, Ozcetin M, Vehapoglu A, Karakaya Z, Aygun F. Acute kidney injury complicated Epstein-Barr virus infection in infancy. Case Rep Pediatr. 2015;2015:848959.

PubMed  PubMed Central  Google Scholar 

Kofteridis DP, Koulentaki M, Valachis A, Christofaki M, Mazokopakis E, Papazoglou G, Samonis G. Epstein Barr virus hepatitis. Eur J Intern Med. 2011;22(1):73–6.

Article  PubMed  Google Scholar 

Schechter S, Lamps L. Epstein-Barr virus hepatitis: a review of clinicopathologic features and differential diagnosis. Arch Pathol Lab Med. 2018;142(10):1191–5.

Article  CAS  PubMed  Google Scholar 

Shah J, Lingiah V, Pyrsopoulos N, Galan M. Acute liver injury due to severe Epstein-Barr virus infection. ACG Case Rep J. 2020;7(2):e00325.

Article  PubMed  PubMed Central  Google Scholar 

Xu JH, Yu YY, Xu XY. Clinical features of Epstein-Barr virus infection associated to liver injury in adolescents and adults. Zhonghua Gan Zang Bing Za Zhi. 2021;29(10):915–8.

CAS  PubMed  Google Scholar 

Bernal KDE, Whitehurst CB. Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients. Virus Res. 2023;334:199157.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wong Y, Meehan MT, Burrows SR, Doolan DL, Miles JJ. Estimating the global burden of Epstein-Barr virus-related cancers. J Cancer Res Clin Oncol. 2022;148(1):31–46.

Article  PubMed  Google Scholar 

Draborg AH, Duus K, Houen G. Epstein-Barr virus in systemic autoimmune diseases. Clin Dev Immunol. 2013;2013:535738.

Article  PubMed  PubMed Central  Google Scholar 

Wang CQ, He J. Ubiquitous distribution of Epstein-Barr virus and the highly uneven distribution of Nasopharyngeal Carcinoma. Chin Med J. 2016;129(20):2506–7.

Article  PubMed  PubMed Central  Google Scholar 

Arjunaraja S, Angelus P, Su HC, Snow A. Impaired control of Epstein-Barr virus infection in B-Cell expansion with NF-κB and T-cell anergy disease. Front Immunol. 2018;9:198.

Article  PubMed  PubMed Central  Google Scholar 

Hanlon P, Avenell A, Aucott L, Vickers MA. Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus. Arthritis Res Ther. 2014;16(1):R3.

Article  PubMed  PubMed Central  Google Scholar 

Hu JH, Zhang XL, Yu GD, Cai H, Gu JQ, Hu ML, Xiang DR, Lian JS, Yu L, Jia HY, Zhang YM, Yang YD. Epstein-Barr virus infection is associated with a higher Child-Pugh score and may predict poor prognoses for patients with liver cirrhosis. BMC Gastroenterol. 2019;19(1):94.

Article  PubMed  PubMed Central  Google Scholar 

Moreira A, Mortatti AL, Arruda AF, Freitas C, de Arruda M, Aoki M. Salivary IgA response and upper respiratory tract infection symptoms during a 21-week competitive season in young soccer players. J Strength Cond Res. 2014;28(2):467–73.

Article  PubMed  Google Scholar 

Shi T, Huang L, Chen Z, Tian J. Characteristics of primary Epstein-Barr virus infection disease spectrum and its reactivation in children, in Suzhou. China J Med Virol. 2021;93(8):5048–57.

Article  CAS  PubMed  Google Scholar 

Kitamura W, Fujiwara H, Matsumura A, Higaki T, Shibata R, Toji T, Fujii S, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Matsuoka KI, Yoshino T, Maeda Y. Chronic active Epstein-Barr virus infection presenting as refractory chronic sinusitis. Int J Hematol. 2022;116(1):139–45.

Article  CAS  PubMed  Google Scholar 

Nadeem A, Suresh K, Awais H, Waseem S. Epstein-Barr Virus Coinfection in COVID-19. J Investig Med High Impact Case Rep. 2021;9:23247096211040624.

PubMed  PubMed Central  Google Scholar 

Liu M, Wang R, Xie Z. T cell-mediated immunity during Epstein-Barr virus infections in children. Infect Genet Evol. 2023;112:105443.

Article  CAS  PubMed  Google Scholar 

Farrington L, Vance H, Rek J, Prahl M, Jagannathan P, Katureebe A, et al. Both inflammatory and regulatory cytokine responses to malaria are blunted with increasing age in highly exposed children. Malar J. 2017;16(1):499.

Article  PubMed  PubMed Central  Google Scholar 

Ge X, Guo Y, Chen J, Hu R, Feng X. Epidemiology and Seasonality of Respiratory Viruses Detected from Children with Respiratory Tract Infections in Wuxi, East China. Med Sci Monit. 2018;24:1856–62.

Article  PubMed  PubMed Central  Google Scholar 

Hsu JY, Tsai CC, Tseng KC. Fulminant hepatic failure and acute renal failure as manifestations of concurrent Q fever and cytomegalovirus infection: a case report. BMC infect Dis. 2014;14:651.

Article  PubMed  PubMed Central  Google Scholar 

Zhang X, Jiang S, Zhou X, Yu Z, Han S, Nan F, Qiao H, Niu D, Wang Z, Niu J, Zhang H, Liu T, Wang Y, Wang B. Human cytomegalovirus-IE2 affects embryonic liver development and survival in transgenic mouse. Cell Mol Gastroenterol Hepatol. 2022;14(2):494–511.

Article  PubMed  PubMed Central  Google Scholar 

Hu J, Zhao H, Lou D, Gao H, Yang M, Zhang X, et al. Human cytomegalovirus and Epstein-Barr virus infections, risk factors, and their influence on the liver function of patients with acute-on-chronic liver failure. BMC Infect Dis. 2018;18(1):577.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Üstündağ H, Danişman Kalindemirtaş F, Doğanay S, Demir Ö, Kurt N, Tahir Huyut M, Özgeriş B, Kariper İA. Enhanced efficacy of resveratrol loaded silver nanoparticle in attenuating sepsis-induced acute liver injury: modulation of inflammation, oxidative stress, and SIRT1 activation. Shock. 2023. https://doi.org/10.1097/SHK.0000000000002218

Liu A, Wang W, Fang H, Yang Y, Jiang X, Liu S, et al. Baicalein protects against polymicrobial sepsis-induced liver injury via inhibition of inflammation and apoptosis in mice. Eur J Pharmacol. 2015;748:45–53.

Article  CAS  PubMed  Google Scholar 

Pan Q, Gao M, Kim D, Ai W, Yang W, Jiang W, Brashear W, Dai Y, Li S, Sun Y, Qi Y, Guo S. Hepatocyte FoxO1 deficiency protects from liver fibrosis via reducing inflammation and TGF-β1 mediated HSC activation. Cell Mol Gastroenterol Hepatol. 2023:S2352–345X(23)00161–3. https://doi.org/10.1016/j.jcmgh.2023.08.013.

Jamann H, Desu HL, Cui QL, Halaweh A, Tastet O, Klement W, Zandee S, Pernin F, Mamane VH, Ouédraogo O, Daigneault A, Sidibé H, Millette F, Peelen E, Dhaeze T, Hoornaert C, Rébillard RM, Thai K, Grasmuck C, Vande Velde C, Prat A, Arbour N, Stratton JA, Antel J, Larochelle C. Activated leukocyte cell adhesion molecule on human oligodendrocytes mediates CD4 T cell adhesion. Brain. 2023:awad286. https://doi.org/10.1093/brain/awad286.

Nakajima K, Hiejima E, Nihira H, Kato K, Honda Y, Izawa K, Kawabata N, Kato I, Ogawa E, Sonoda M, Okamoto T, Okajima H, Yasumi T, Takita J. Case report: a case of Epstein-Barr virus-associated acute liver failure requiring hematopoietic cell transplantation after emergent liver transplantation. Front Immunol. 2022;13:825806.

Article  CAS  PubMed  PubMed Central  Google Scholar